Highly mutated cancers respond better to immune therapy
Highly mutated cancers respond better to immune therapy, Published online: 14 January 2019; doi:10.1038/d41586-019-00143-8
The complex tests that gauge mutation levels will pose a challenge in the clinic.
from A via a.sfakia on Inoreader https://go.nature.com/2RqpNoB
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,